低浓度阿托品在儿童近视控制中的研究进展

Research Progress of Low-Concentration Atropine for Myopia Control in Children

伴随着儿童近视发生率的上升和低龄化趋势,近视已成为亟需解决的全球公共卫生问题。控制近视发生发展的有效措施包括双焦眼镜、多焦眼镜、角膜塑形镜和药物等。近年来,阿托品作为控制近视发展的有效药物得到广泛关注。由于低浓度阿托品可以有效控制近视屈光度和眼轴增长,且畏光、视近模糊等不良反应轻,故低浓度阿托品已成为儿童近视防控的研究重点。现就低浓度阿托品在儿童近视控制中的研究进展进行综述。

With the increasing incidence of myopia in children and a younger age of myopia onset,myopia has become a global public health problem,which needs to be addressed immediately.Effective interventions for myopia control include bifocal glasses,multi-focal glasses,orthokeratology lens and pharmacologic,etc.Recently,atropine eye drops have obtained widespread concern for its effectiveness in suppressing the myopia progression.As low-dose atropine can effectively control myopia progression and axial growth,with significantly less adverse events such as photophobia and blurred near vision compared to higher concentration preparation,low-concentration atropine has become one of the important research areas for myopia prevention and control in children.This article summarizes the research progress of low-concentration atropine in myopia control of children.